key: cord-0875661-ssddbcpx authors: Al‐Metwali, Basma Zuheir; Al‐Jumaili, Ali Azeez; Al‐Alag, Zahraa Adel; Sorofman, Bernard title: Exploring the acceptance of COVID‐19 vaccine among healthcare workers and general population using health belief model date: 2021-05-07 journal: J Eval Clin Pract DOI: 10.1111/jep.13581 sha: 7ff9b8efeee17dc398325fcc4e245ca754f4cad7 doc_id: 875661 cord_uid: ssddbcpx RATIONALE, AIMS AND OBJECTIVES: Little is known about hesitancy to receive the COVID‐19 vaccines. The objectives of this study were (1) to assess the perceptions of healthcare workers (HCWs) and the general population regarding the COVID‐19 vaccines, (2) to evaluate factors influencing the acceptance of vaccination using the health belief model (HBM), and (3) to qualitatively explore the suggested intervention strategies to promote the vaccination. METHODS: This was a cross‐sectional study based on electronic survey data that was collected in Iraq during December first‐19th, 2020. The electronic survey was designed using Qualtrics. HBM was followed to develop the survey items. A regression analysis was used to identify factors influencing people accepting vaccination. Thematic analysis for participant comments to an open‐ended question. RESULTS: A total of 1680 completed surveys were received. The mean age of 31.2 ± 9.9 years, 53.0% were female and 47.0% were male. The largest group was HCWs (45.7%), followed by general population (37.5%) and health college students (16.8%). Our findings expressed some hesitancy to receive the COVID‐19 vaccine with the acceptance rate of 61.7%. The HCWs perceived significantly higher susceptibility and severity of the COVID‐19 infection compared to the general population. The HCWs were significantly more likely than the general population to receive COVID‐19 vaccine. Concerns with proper storage was the biggest barrier to vaccine receipt. The regression analysis indicated eight factors that were significantly associated with the willingness to receive COVID‐19 vaccine: Preventive measures, perceived benefit, perceived barriers, cue to action, subjective norm, supportive of vaccination in general and having received a flu vaccine before. CONCLUSIONS: Awareness campaign can focus on enhancing the vaccine perceived benefit, debunking misconceptions, and increasing the disease perceived severity. Additionally, the public health leaders need to minimize the perceived barriers by providing the vaccines and appeasing people concerns about their storage, effectiveness, and adverse events. The coronavirus disease of 2019 , caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has resulted in a major impact on the global health and economics since its emergence at the end of 2019. As of 16 April 2021 more than 139 million cases and over 2.99 million deaths have occurred globally since the start of the pandemic. 1 Different treatment strategies have been employed to manage the disease, 2,3 however, the number of cases and deaths continue to increase. Therefore, preventive measures, such as social distancing and wearing facial masks, represent a pivotal strategy to reduce the transmission rates of the disease. 4 In addition, there is an urgent need for a vaccine in order to effectively prevent spread of infections. Several vaccines have been developed against SARS-CoV-2 and have shown promising results in clinical trials. [5] [6] [7] One of the leading examples is the mRNA-based vaccine (known as BNT162b2) developed by Pfizer-BioNTech pharmaceutical companies, which demonstrated to be safe and offer protection in subjects after receiving the second dose. 8 Additionally, mRNA-based vaccine (known as mRNA-1273) developed by Moderna showed favourable results in clinical trials published in the New England Journal of Medicine. 5 Both vaccines were granted emergency use authorization by the Food and Drug Administration (FDA) and European Medicines Agency (EMA), respectively. Another promising vaccine is the DNA-based vaccine (known as Vaxzevria) developed by Oxford-AstraZeneca which was authorized for use by the U.K Medicines and Healthcare products Regulatory Agency (MHRA). 9 The World Health Organization (WHO) granted emergency validation to the Pfizer/BioNTech and AstraZeneca COVID-19 vaccine. 10 A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V) was developed by the Gamaleya Center, Russia. 11 Lastly, two inactivated virus vaccines were developed by Sinovac and Sinopharm in China. 12 As of January 20, the National Committee for Drug Selection at Iraqi Ministry of Health (MOH) approved three vaccines for emergency use: Pfizer/BioNTech, AstraZeneca and Sinopharm. Thereafter, the MOH ordered millions of doses from the Pfizer/BionTech, AstraZeneca and Sinopharm vaccines. On 28 February 2021, the first batch of COVID-19 vaccines was received by Iraqi MOH. 13 Yet, despite the existing data on the safety and effectiveness of the vaccines, scepticism regarding their use exists worldwide. For example, in June 2020, the acceptance rate of COVID-19 vaccine in Russia was 55% and in France was 59%. 14 This may present a problem as it is required that a majority of the population receives the vaccine to build herd immunity. Therefore, it is pivotal to understand the perceptions and motivations of the population toward the candidate COVID-19 vaccine. Existing evidence provides some information regarding the public openness to receive the candidate COVID-19 vaccines. 14 However, little is known about the perceptions and beliefs the populations hold regarding the vaccines as well as the motivations behind accepting or resisting them. It is particularly interesting to predict how this will play out in the Middle East as we are not currently aware of any such surveys conducted in the region. The objectives of this study were (1) to assess the perceptions of healthcare workers (HCWs) and the general population of the candidate COVID-19 vaccines, (2) Health belief model (HBM) 15 can serve as a useful theoretical framework not only to explore the motives of individuals willing to vaccinate, but even more importantly to investigate the reasons behind refusing vaccination. The major premise of this model is that existing beliefs can predict future behaviours. When applied to disease prevention, it suggests that one's willingness to prevent an illness combined with their expectations of a particular action (such as receiving a vaccine) can serve as a predictor for future behaviours. HBM includes five major constructs, namely: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, and cues to action 15 (Figure 1 ). Perceived susceptibility refers to an individual's belief about the likelihood of acquiring a disease. Perceived severity refers to the individual's feelings of the severity of such illness. Perceived benefits construct is related to one's perception of the usefulness of a particular health behaviour. Perceived barriers correspond to the individual's assessment of obstacles that could prevent people from performing that particular health behaviour. Lastly, cues to action, refer to the cues that stimulate a specific behaviour. 16 The study items were adopted with modification from a previous study which assessed perceptions of healthcare providers regarding flu vaccines. 17 To eliminate the language barrier, the general population survey was translated to formal Arabic by the authors and the translation was validated by two bilingual native Arabic scholars. The survey was pretested in a pilot study with 40 participants. Cronbach alpha was measured for the pilot study to make sure the items represented the measured HBM domains. Additionally, appropriate revisions were conducted according to the pilot study feedback. p-value of less than 0.05 was considered statistically significant. During the qualitative analysis stage, we needed to identify the themes from the participant comments. We followed the six phases of thematic analysis described by Braun and Clarke, 2006 which include familiarizing with data (comments), generating initial codes, searching for themes, reviewing themes, defining and naming themes and producing the report. 18 The comments were cross-checked by three research team members. Inductive analytic methodology (data-driven) was used and constructivist paradigm was followed for the qualitative phase. 19 This means we did not rely on the HBM to come with the themes, but we construct the themes and subthemes from the common trends emerging from the participant comments. Finally, to enhance the credibility and trustworthiness of the findings, peer checking/debriefing was performed two times to validate the qualitative analysis. 20 A total of 1967 surveys were conducted. 287 subjects were excluded due to completing less than 90% of the questions, yielding 1680 completed surveys. As summarized in Table 1 , the characteristics of participants were the following: Mean age of 31.2 ± 9.9 years, 53.0% were female and 47.0% were male. Additionally, 70.3% of participants had college degree or higher education. The majority of participants were HCWs (45.7%), followed by general population (37.5%) and health college students (16.8%). More than 42% of the participants had family members or close friends died from COVID-19 infection. Two-thirds (63.7%) of the respondents were from Baghdad, but participation was noted from all provinces. Perceptions of respondents toward vaccination was summarized in Table 2 . About two-thirds (62.8%) of the participants were supportive of vaccination in general. More than half (61.7%) of respondents strongly agreed or somewhat agreed to take the prospective COVID-19, 22.7% were undecided, and only 15.6% were not planning to take the vaccine. More than two-thirds (68.3%) of the participants reported social media, newspapers, and television as sources of information on COVID-19 vaccines. In contrast, 44.7% rely on scientific sources such as scientific webinars or scientific publications and 20.1% rely on healthcare providers (HCPs) (physicians or pharmacists) as a source of the vaccine information. Lastly, 5.5% of participants reported not being informed. High compliance with preventive measures was observed in more than two thirds of respondents. This was noted in those who implemented the desired preventive action either always or often times. More specifically, 89.8% of respondents reported handwashing, 82.8% reported wearing facemask outside home, 76.2% reported using handsanitizers and 72.6% reported avoiding social gathering (Table 3 ). In the Mann-Whitney test to compare the willingness to receive the vaccine, health college students were considered as part of general population as they have not graduated yet. The Mann-Whitney test shows that HCWs were significantly (p-value <0.05) more likely than the general population to follow preventive measures and receive COVID-19 vaccine. These differences are outlined in Table 4 . In respect to the HBM domains, perceived susceptibility and severity of the COVID-19 infection and perceived benefit of the vaccine were all noted in the majority of respondents. It is worth mentioning that HCWs perceived significantly (p-value <0.05) higher susceptibility and severity of the COVID-19 infection compared to the general population (Table 4) . Specifically, 73.8% reported being at high risk of infection and 61.9% reported concerns about the infection. Additionally, 76.0% believed that COVID-19 infection to be fatal and 87.5% perceived it to be more serious than influenza infection. As far as perceived benefits, the vaccines were thought to be effective (63.4%) and to protect the respondents (57.0%) and their families (64.5%) from the infection (Table 5) . Table 6 ). According to the Mann-Whitney test, the general population perceived significantly (p-value <0.05) higher barriers and cue to action toward the vaccination compared to the HCWs (Table 4) . Lastly, the influence of subjective norms (such as peers) on one's acceptance to vaccinate was evaluated. Accordingly, 66.0% of the respondents reported willingness to vaccinate if their colleagues /friends were to be vaccinated first ( Table 6 ). The internal validity (reliability) of the items in each scale was measured using Cronbach's alpha. All the Cronbach's Alpha values were above 0.6 and hence were accepted, with the exception of perceived barrier, which was 0.59 (Table 7 ). In addition, the perceived barriers scale had three items with the highest mean (4.25) corresponding to concern about the vaccine storage condition. Other (Table 8 ). As far as the qualitative section of the survey, participants were asked to suggest interventions to promote COVID-19 vaccine awareness. The findings from the thematic analysis can be divided into three main parts: Intervention strategies, the content of the awareness campaigns and the barriers facing people toward accepting COVID-19 vaccine. Regarding the intervention strategies, the participants suggested multifaceted awareness campaign in addition to forcing the vaccination. Respondents emphasized the use of media sources such as social media and television to draw attention and increase public trust. Furthermore, HCWs' advice and awareness campaigns were Table S1 ). In terms of HBM, the awareness campaign comments basically focused on enhancing the perceived benefit of the vaccine and increasing perceived severity of the disease (COVID-19) . Additionally, they also referred to cue to action strategies by the MOH, the WHO and media awareness campaign (see the supplementary- Table S1 ). The qualitative data collected also included barriers behind partici- Employing the HBM has revealed useful information about the influence of the various domains on the acceptance of the vaccine. According to the regression analysis, three HBM factors had significant positive association with the willingness to receive the vaccines including perceived benefits, the cues to action, and subjective norm. Conversely, participants who expressed high barriers were significantly less likely to be vaccinated. Perceived benefits of the vaccines were also noted in our study. The majority of participants felt that the vaccine would be effective (63.4%) and would protect them (57%) and their families (64.5%) from getting the infection. Belief in the vaccine benefit to prevent infections and subsequent complications was also common among Chinese populations. 25 Involvement of HCPs and collaboration with the WHO for the awareness campaigns was also recommended. Although this study has a unique method integrating quantitative and qualitative findings, it experienced some limitations. One is the small size, and the other limitation is that most of the respondents were from Baghdad, and therefore it is perhaps not a true representation of the entire population in Iraq. The HBM successfully predicted the factors influencing the people acceptance of vaccination against COVID-19. Our findings expressed some hesitancy to receive the COVID-19 vaccine with the acceptance rate of 61.7%. Concern with proper storage was seen as the biggest reported barrier to vaccine receipt. Reliance on social media, newspaper and television for vaccine information was noted in this survey. Additionally, the WHO and healthcare providers were seen as a reliable source of recommendations. The participant comments showed awareness campaign with multifaceted strategies is necessary to enhance people awareness and likelihood to accept the vaccination. This campaign should focus on enhancing the vaccine perceived benefit, debunking misconceptions, and increasing the disease perceived severity. Additionally, the public health officials need to minimize the perceived barriers by providing the vaccines and appeasing people concerns about their effectives, adverse events and storage. The authors would like to thank all healthcare workers and people who participated in this study. There is no funding for the study. No conflict of interest to declare. Ali Azeez Al-Jumaili https://orcid.org/0000-0003-4691-0280 Bernard Sorofman https://orcid.org/0000-0003-0157-9694 Potential treatments for COVID-19; a narrative literature review Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review A review of current interventions for COVID-19 prevention Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet FDA briefing document Pfizer-BioNTech COVID-19 vaccine AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK. 2020. Accessed World Health Organization. WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia Current advances in the development of SARS-CoV-2 vaccines Iraqi Ministry of Health. MOH Official website A global survey of potential acceptance of a COVID-19 vaccine The health belief model and preventive health behavior Why people use health services. The Milbank Quarterly Pandemic influenza A/H1N1 vaccination uptake among health care workers in Qatar: motivators and barriers Using thematic analysis in psychology Designing and Conducting Mixed Methods Research Establishing trustworthiness and authenticity in qualitative pharmacy research Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults Social media can have an impact on how we manage and investigate the COVID-19 pandemic Social media influence in the COVID-19 pandemic Trends and predictors of COVID-19 information sources and their relationship with knowledge and beliefs related to the pandemic: Nationwide cross-sectional study Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China Willingness to get the COVID-19 vaccine with and without emergency use authorization Impact of COVID-19 pandemic on healthcare providers: save the frontline fighters Can developing countries face novel coronavirus outbreak alone? The Iraqi situation Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots Food and Drug Administration Evaluating factors related to the abuse of Oral corticosteroids among community pharmacy customers: using theory of reasoned action Additional supporting information may be found online in the Supporting Information section at the end of this article.